glp-1 agonists vision loss blindness NAION Lawsuit GLP-1 Receptor Agonists and the

Activation of both GIP and GLP-1 receptors by retatrutide probably contributed to the observed changes in circulating triglycerides, as treatment with the dual GIP/GLP-1 receptor agonist tirzepatide significantly reduced triglyceride levels by up to 29% at 52 weeks in a clinical trial in people with T2D and MASLD 8

The stack stimulates your own growth hormone, not replacing it

Use it twice daily, morning and evening, for optimal results

Seek medical attention for excessive thirst with frequent urination, pain during urination, blood in urine, or signs of dehydration or infection

Going forward, additional research could include larger, long-term clinical trials to determine if peptide therapy benefits extend beyond AMH numbers, like supporting live birth rates or overall ovarian health